Cargando…
Transcriptome profiles acquired during cell expansion and licensing validate mesenchymal stromal cell lineage genes
BACKGROUND: Mesenchymal stromal cells (MSCs) are rapidly advancing as commercial therapeutics. However, there are still no adequate tools to validate the identity of MSCs and support standardization of MSC-based products. Currently accepted metrics include cell surface marker profiling and tri-linea...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427746/ https://www.ncbi.nlm.nih.gov/pubmed/32795342 http://dx.doi.org/10.1186/s13287-020-01873-7 |